Synapse - Works

Results (5611)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: A report from the Children’s Oncology Group

Journal Article

Kopp, L. M.; Womer, R. B.; Schwartz, C. L.; Ebb, D. H.; Franco, V. I.; Hall, D.; Barkauskas, D. A.; Krailo, M. D.; Grier, H. E.; Meyers, P. A.; more...
Cardio-Oncology (2019)

Fulltext@MSK | Save

Can intra-fraction prostate motion during stereotactic body radiation therapy be predicted based on pre-treatment anatomy?

Meeting Abstract

Jacobs, L.; Gorovets, D.; Burleson, S.; Happersett, L.; Hunt, M.; Zelefsky, M.
Journal of Radiation Oncology (2019)

Fulltext@MSK | Save

High-signal bladder urine at T(1)-weighted MR imaging performed 1–7 days after a prior gadolinium-enhanced MRI: Prevalence and correlation with renal function

Journal Article

Foran, P.; Hwang, S.; Mazaheri, Y.; Panicek, D. M.
BJR Open (2019)

Fulltext@MSK | Save

Stereotactic prostate focal reirradiation therapy for local recurrence: Preliminary results of Hartmann Oncology Radiotherapy Group

Journal Article

Scher, N.; Bauduceau, O.; Bollet, M.; Lamallem, H.; Charas, T.; Garaud, P.; Foster, D.; Fawzi, M.; Labidi, M.; Toledano, A.
BJR Open (2019)

Fulltext@MSK | Save

Differences in degree of lesion enhancement on CEM between ILC and IDC

Journal Article

van Nijnatten, T. J. A.; Jochelson, M. S.; Pinker, K.; Keating, D. M.; Sung, J. S.; Morrow, M.; Smidt, M. L.; Lobbes, M. B. I.
BJR Open (2019)

Fulltext@MSK | Save

A phase I study of CC-90002, a monoclonal antibody targeting CD47, in patients with relapsed and/or refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS): Final results

Meeting Abstract

Zeidan, A. M.; DeAngelo, D. J.; Palmer, J. M.; Seet, C. S.; Tallman, M. S.; Wei, X.; Li, Y. F.; Hock, N.; Burgess, M. R.; Hege, K.; more...
Blood (2019)

Fulltext@MSK | Save

Aberrant SYK expression as a potential therapeutic target in T/NK cell neoplasms

Meeting Abstract

Zhang, J. P.; Gao, Q.; Chan, A.; Xiao, W.; El Daker, S.; Roshal, M.; Dogan, A.
Blood (2019)

Fulltext@MSK | Save

The genomic and transcriptomic landscape of double-refractory multiple myeloma

Meeting Abstract

Ziccheddu, B.; Biancon, G.; De Philippis, C.; Bagnoli, F.; Maura, F.; Dugo, M.; Devecchi, A.; De Cecco, L.; Sensi, M.; Terragna, C.; more...
Blood (2019)

Fulltext@MSK | Save

ME-401-003 (TIDAL): A multicenter, randomized, double-blind, placebo-controlled, two-arm, phase 2 study of ME-401 investigating continuous and intermittent dosing schedules in patients with relapsed/refractory follicular lymphoma

Meeting Abstract

Zelenetz, A. D.; Zinzani, P. L. L.; Chan, H.; Buske, C.; Ribrag, V.; Cunningham, D.; Jurczak, W.; Abrisqueta, P.; Li, J.; Gorbatchevsky, I.; more...
Blood (2019)

Fulltext@MSK | Save

Safety and efficacy of atezolizumab in combination with rituximab plus CHOP in previously untreated patients with diffuse large B-cell lymphoma (DLBCL): Updated analysis of a phase I/II study

Meeting Abstract

Younes, A.; Burke, J. M.; Cheson, B. D.; Diefenbach, C.; Ferrari, S.; Hahn, U. H.; Hawkes, E. A.; Khan, C.; Lossos, I. S.; Musuraca, G.; more...
Blood (2019)

Fulltext@MSK | Save